AR009802A1 - Formulacion recubierta en particulas - Google Patents

Formulacion recubierta en particulas

Info

Publication number
AR009802A1
AR009802A1 ARP970104363A ARP970104363A AR009802A1 AR 009802 A1 AR009802 A1 AR 009802A1 AR P970104363 A ARP970104363 A AR P970104363A AR P970104363 A ARP970104363 A AR P970104363A AR 009802 A1 AR009802 A1 AR 009802A1
Authority
AR
Argentina
Prior art keywords
particles
formulation coated
formulation
coated
olanzapine
Prior art date
Application number
ARP970104363A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR009802A1 publication Critical patent/AR009802A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Proporciona una formulacion oral solida de olanzapina farmacéuticamente aceptable y un proceso para la elaboracion de dicha formulacion.
ARP970104363A 1996-09-24 1997-09-23 Formulacion recubierta en particulas AR009802A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2663396P 1996-09-24 1996-09-24

Publications (1)

Publication Number Publication Date
AR009802A1 true AR009802A1 (es) 2000-05-03

Family

ID=21832952

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970104363A AR009802A1 (es) 1996-09-24 1997-09-23 Formulacion recubierta en particulas

Country Status (21)

Country Link
US (1) US20010020032A1 (es)
EP (1) EP0830858A1 (es)
JP (1) JP2001501207A (es)
KR (1) KR20000048540A (es)
CN (1) CN1230883A (es)
AR (1) AR009802A1 (es)
AU (1) AU719788B2 (es)
BR (1) BR9713215A (es)
CA (1) CA2266448A1 (es)
CO (1) CO4910139A1 (es)
CZ (1) CZ98899A3 (es)
EA (1) EA001610B1 (es)
HU (1) HUP9904065A3 (es)
ID (1) ID21762A (es)
IL (1) IL128845A0 (es)
NO (1) NO991405L (es)
PE (1) PE27899A1 (es)
PL (1) PL332503A1 (es)
TR (1) TR199900651T2 (es)
WO (1) WO1998013027A1 (es)
ZA (1) ZA978517B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9922271D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Formulation
TWI275394B (en) * 2000-01-26 2007-03-11 Asahi Chemical Corp Mizoribin tablet improved with color tone change
US6740753B2 (en) 2001-01-04 2004-05-25 Geneva Pharmaceuticals, Inc. Olanzapine crystal modification
DE10232113A1 (de) * 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
SI21303A (sl) * 2002-10-18 2004-04-30 Krka, Tovarna Zdravil, D.D.,, Novo Mesto Farmacevtska formulacija olanzapina
CA2510320C (en) 2002-12-20 2012-10-09 St. James Associates Llc/Faber Research Series Coated particles for sustained-release pharmaceutical administration
SI21402A (sl) 2003-02-12 2004-08-31 LEK farmacevtska dru�ba d.d. Obloženi delci in farmacevtske oblike
JP4808612B2 (ja) * 2003-04-25 2011-11-02 田辺三菱製薬株式会社 アルキレンジオキシベンゼン誘導体を含む経口投与用組成物
WO2005009407A2 (en) * 2003-07-29 2005-02-03 Ranbaxy Laboratories Limited Oral pharmaceutical formulations of olanzapine
WO2006027800A1 (en) * 2004-09-06 2006-03-16 Shasun Chemicals And Drugs Limited A novel process for preparation of a pharmaceutically pure polymorphic form 1 of olanzapine
CZ297214B6 (cs) * 2005-02-02 2006-10-11 Zentiva, A. S. Lécivý prípravek obsahující jako úcinnou slozku olanzapin a zpusob jeho výroby
WO2007049304A2 (en) * 2005-10-27 2007-05-03 Jubilant Organosys Limited Stable coated pharmaceutical formulation of olanzapine and process for preparing the same
ES2279715B1 (es) * 2005-12-26 2008-06-01 Laboratorios Lesvi, S.L. Formulacion oral de olanzapina.
WO2007134845A2 (en) * 2006-05-18 2007-11-29 Synthon B.V. Olanzapine pharmaceutical composition
DE602006014030D1 (de) * 2006-07-05 2010-06-10 Bilim Ilac Sanayii Ve Ticaret Stabile olanzapin-formulierung mit antioxidantien
US20080138409A1 (en) * 2006-09-29 2008-06-12 Osinga Niels J Olanzapine pharmaceutical composition
PH12012502019A1 (en) * 2010-04-30 2017-08-18 Bristol Myers Squibb Co Pharmaceutical compositions comprising n-(4-(2-amino -3-chloropyridin -4-yloxy) -3-fluorophenyl) -4-ethoxy-l- (4-fluorophenyl) -2-oxo-1,2- dihydropyridine-3-carboxamide
WO2012153347A2 (en) 2011-05-04 2012-11-15 Zentiva K.S. Oral pharmaceutical composition of olanzapine form 1
CA2907765C (en) 2013-03-21 2021-07-06 Eupraxia Pharmaceuticals USA LLC Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
TW201720427A (zh) 2015-10-27 2017-06-16 優普順藥物股份有限公司 局部麻醉劑之持續釋放調配物
CN107007559B (zh) * 2017-04-21 2020-05-15 浙江京新药业股份有限公司 一种稳定的口服药物组合物及其制备方法
WO2019113084A1 (en) 2017-12-05 2019-06-13 Sunovion Pharmaceuticals Inc. Crystal forms and production methods thereof
CN118593482A (zh) 2017-12-05 2024-09-06 赛诺维信制药公司 非外消旋混合物及其用途
MX2021014774A (es) 2019-06-04 2022-02-03 Sunovion Pharmaceuticals Inc Formulaciones de liberacion modificada y usos de las mismas.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820522A (en) * 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
US5605897A (en) * 1991-04-23 1997-02-25 Eli Lilly And Company 2-methyl-thieno-benzodiazepine
ZA922776B (en) * 1991-04-29 1993-10-15 Lilly Co Eli Pharmaceutical compounds
JPH05194225A (ja) * 1991-11-07 1993-08-03 Yoshitomi Pharmaceut Ind Ltd 安定化された抗潰瘍剤含有製剤
AU668159B2 (en) * 1992-05-29 1996-04-26 Lilly Industries Limited Pharmaceutical compounds
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
IL117612A0 (en) * 1995-03-24 1996-07-23 Lilly Co Eli Granule formulation for olanzapine
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine

Also Published As

Publication number Publication date
JP2001501207A (ja) 2001-01-30
IL128845A0 (en) 2000-01-31
NO991405D0 (no) 1999-03-23
CZ98899A3 (cs) 1999-12-15
ID21762A (id) 1999-07-22
CA2266448A1 (en) 1998-04-02
TR199900651T2 (xx) 1999-07-21
ZA978517B (en) 1999-03-23
CO4910139A1 (es) 2000-04-24
EA199900331A1 (ru) 2000-04-24
HUP9904065A3 (en) 2001-10-29
PE27899A1 (es) 1999-03-12
AU4423097A (en) 1998-04-17
AU719788B2 (en) 2000-05-18
US20010020032A1 (en) 2001-09-06
EP0830858A1 (en) 1998-03-25
BR9713215A (pt) 2000-04-04
KR20000048540A (ko) 2000-07-25
WO1998013027A1 (en) 1998-04-02
NO991405L (no) 1999-03-23
EA001610B1 (ru) 2001-06-25
CN1230883A (zh) 1999-10-06
HUP9904065A2 (hu) 2000-04-28
PL332503A1 (en) 1999-09-13

Similar Documents

Publication Publication Date Title
HUP9900457A3 (en) Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
AU7558796A (en) Fast-melt solid dosage form and method of making same
ZA969001B (en) Method compositions and kits for increasing the oral bioavailability of pharmaceutical agents
MY113440A (en) Oral 2-methyl-thieno-benzodiazepine formulation
PL304060A1 (en) Solid dosed form of prolonged release for oral administration and method of obtaining same,
HUP9802315A3 (en) Thrombin inhibitors, process for producing them and use of them for producing pharmaceutical compositions
IL124559A0 (en) Metalloproteinase inhibitors pharmaceutical compositions containing them and their pharmaceutical uses and methods and intermediates useful for their preparation
HUP0203374A3 (en) Sold oral pharmaceutical composition and process for its preparation
CA2179540A1 (en) Accelerated release composition containing bromocriptine
AU6931396A (en) Toothbrush and method for its manufacture
DE69637030D1 (de) Beschichtetes Reinigungsmittels in Tablettenform und Herstellungsverfahren dafür
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
AU9019391A (en) Temporary stent and methods for use and manufacture
IS4635A (is) 4-fenýlamínóþíasólafleiður, aðferð við að framleiða þær og lyfjablöndur sem innihalda þær
AU2478595A (en) Expanding dental implant and method of use
AU1912197A (en) New inhibitors of metalloprotease, process for preparing them and pharmaceutical compositions containing them
FI960208A7 (fi) Päällystettyjä natriumperkarbonaattihiukkasia, menetelmä niiden valmis tamiseksi ja niiden käyttö
NO991405L (no) Belagt partikkelformulering
AU6125396A (en) Serum-free media for primitive hematopoietic cells and metho ds of use thereof
AU1283588A (en) New pharmaceutical compositions in the form of beadlets and method
HUP9802408A3 (en) Naphthyl and dihydronaphthyl-derivatives, and pharmaceutical compositions, containing them
HUP9800573A3 (en) Rapamycin formulations for oral administration and process for their preparation
PL321810A1 (en) Drug form releasing the collagenase onto wounds and method of obtaining same
HUP9801683A3 (en) Composition for cleaning surfaces and process for their use
AU5101798A (en) Method for oral administration of buspirone